Serious Event

Serious Event

Serious Adverse Events (SAEs) are adverse events that result in death, are life-threatening, require or prolong hospitalization, cause persistent or significant disability/incapacity, or are congenital anomalies/birth defects. Each serious event is categorized by term, organ system, assessment type, and source vocabulary to provide standardized reporting across clinical trials.

Serious Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Serious Event

Study -> Results Section -> Adverse Events Module -> Serious Event -> Serious Event Stats

Serious Event


Ignite Creation Date: 2025-12-24 @ 12:48 PM
Ignite Modification Date: 2025-12-25 @ 12:15 PM
NCT ID: NCT01606761
Term: Herpes Zoster
Organ System: Infections and infestations
Assessment Type: NON_SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA Version 17.0
Notes: None
Study: NCT01606761
Study Brief: A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T)
Serious Event Stats (If Any):

Serious Event Stats

Group ID # Events # Affected # At Risk View
EG000 None 0 294 View
EG001 None 0 124 View
EG002 None 1 292 View
EG003 None 0 126 View
EG004 None 0 292 View
EG005 None 0 28 View
EG006 None 0 7 View
EG007 None 0 65 View
EG008 None 0 19 View
EG009 None 0 62 View